TapewireFind a company

person · Reporting owner

Thomas John

Disclosed activity across 1 company

Tapewire entity
36757
SEC CIK
0001939103

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
GENELUX CorpGNLX · Entity 1116DirectorJune 16, 2026June 18, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

GENELUX Corp

Report date June 16, 2026 · Filed June 18, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect501,193 Reported balance After 2026-06-16 transaction · row 1
1 source row

Row 1 · 2026-06-16 · Grant · Acquired 28,409 · Balance 501,193

F1: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.03 · Expires 2036-06-15Direct31,566 Reported balance After 2026-06-16 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-06-16 · Grant · Acquired 31,566 · Balance 31,566

F2: The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.

Filing footnotes · ownership attribution and instrument terms

F1: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.

F2: The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 16, 2026 Filed Jun 18, 2026 23:05 UTC GENELUX Corp GNLX · Entity 1116 GrantStock Option (Right to Buy) · Derivative 31,566 $0.00 Strike: $3.03 $0.00
Disclosure

SEC source: 0001493152-26-029416 · ownership.xml · derivative · entry 2

Thomas John · CIK 0001939103 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,566

Underlying: Common stock · 31,566 shares

Expires 2036-06-15

F2 · derivative.exercise_date: The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 23:05 UTC GENELUX Corp GNLX · Entity 1116 GrantCommon Stock 28,409 $0.00 $0.00
Disclosure

SEC source: 0001493152-26-029416 · ownership.xml · nonDerivative · entry 1

Thomas John · CIK 0001939103 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 501,193

F1 · kind: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 00:35 UTC GENELUX Corp GNLX · Entity 1116 SaleCommon Stock 10,000 $2.98 $29,801.00
Disclosure

SEC source: 0001493152-26-026930 · ownership.xml · nonDerivative · entry 1

Thomas John · CIK 0001939103 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 472,784

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2025.

F2 · price: The weighted average sale price for the transaction reported was $2.9801, and the range of prices were between $2.94 and $3.05. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 01:05 UTC GENELUX Corp GNLX · Entity 1116 SaleCommon Stock 10,000 $2.90 $28,957.00
Disclosure

SEC source: 0001493152-26-008743 · ownership.xml · nonDerivative · entry 1

Thomas John · CIK 0001939103 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 482,784

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2025.

F2 · price: The weighted average sale price for the transaction reported was $2.8957, and the range of prices were between $2.82 and $3.01. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Read SEC document
December 01, 2025 Filed Dec 3, 2025 00:00 UTC GENELUX Corp GNLX · Entity 1116 SaleCommon Stock 10,000 $5.00 $50,008.00
Disclosure

SEC source: 0001493152-25-025811 · ownership.xml · nonDerivative · entry 1

Thomas John · CIK 0001939103 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 492,784

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2025.

F2 · price: The weighted average sale price for the transaction reported was $5.0008, and the range of prices were between $4.73 and $5.34. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Read SEC document
August 27, 2025 Filed Aug 29, 2025 20:30 UTC GENELUX Corp GNLX · Entity 1116 GrantStock Option (Right to Buy) · Derivative 28,576 $0.00 Strike: $3.64 $0.00
Disclosure

SEC source: 0001641172-25-026003 · ownership.xml · derivative · entry 2

Thomas John · CIK 0001939103 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,576

Underlying: Common stock · 28,576 shares

Expires 2035-08-26

F2 · derivative.exercise_date: The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
August 27, 2025 Filed Aug 29, 2025 20:30 UTC GENELUX Corp GNLX · Entity 1116 GrantCommon Stock 22,283 $0.00 $0.00
Disclosure

SEC source: 0001641172-25-026003 · ownership.xml · nonDerivative · entry 1

Thomas John · CIK 0001939103 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 502,784

F1 · kind: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
June 06, 2025 Filed Jun 24, 2025 20:10 UTC GENELUX Corp GNLX · Entity 1116 GiftCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-018048 · form4-06242025_040601.xml · nonDerivative · entry 1

Thomas John · CIK 0001939103 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 480,501

Read SEC document
August 01, 2024 Filed Aug 5, 2024 22:35 UTC GENELUX Corp GNLX · Entity 1116 GrantStock Option Right to Buy) · Derivative 50,469 $0.00 Strike: $1.54 $0.00
Disclosure

SEC source: 0001415889-24-020779 · form4-08052024_100850.xml · derivative · entry 2

Thomas John · CIK 0001939103 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,469

Underlying: Common Stock · 50,469 shares

Expires 2034-07-31

F2 · derivative.exercise_date: The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 22:35 UTC GENELUX Corp GNLX · Entity 1116 GrantCommon Stock 39,541 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-020779 · form4-08052024_100850.xml · nonDerivative · entry 1

Thomas John · CIK 0001939103 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 505,501

F1 · kind: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
August 01, 2024 Filed Dec 31, 2024 18:20 UTC Amendment GENELUX Corp GNLX · Entity 1116 GrantStock Option Right to Buy) · Derivative 50,469 $0.00 Strike: $1.96 $0.00
Disclosure

SEC source: 0001415889-24-030277 · form4a-12312024_011207.xml · derivative · entry 1

Thomas John · CIK 0001939103 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,469

Underlying: Common Stock · 50,469 shares

Expires 2034-07-31

F1 · derivative.exercise_date: The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
May 29, 2024 Filed Jun 8, 2024 01:45 UTC GENELUX Corp GNLX · Entity 1116 PurchaseCommon Stock Warrant (Right to Buy) · Derivative 2,500 Not disclosed Strike: $5.25 Not disclosed
Disclosure

SEC source: 0001415889-24-016108 · form4-06072024_090608.xml · derivative · entry 2

Thomas John · CIK 0001939103 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Stock · 2,500 shares

Expires 2029-05-29

F1 · kind: The Reporting Person's purchase reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the Reporting Person's sale of common stock on December 13, 2023. The Reporting Person has agreed to pay to the Issuer the profit realized in connection with the short-swing transaction, less transaction costs.

F2 · price: The reported securities consist of shares of common stock sold together with accompanying warrants to purchase common stock. The combined price of each share of common stock offered together with one warrant was $4.00.

Read SEC document
May 29, 2024 Filed Jun 8, 2024 01:45 UTC GENELUX Corp GNLX · Entity 1116 PurchaseCommon Stock 2,500 Not disclosed Not disclosed
Disclosure

SEC source: 0001415889-24-016108 · form4-06072024_090608.xml · nonDerivative · entry 1

Thomas John · CIK 0001939103 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 465,960

F1 · kind: The Reporting Person's purchase reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the Reporting Person's sale of common stock on December 13, 2023. The Reporting Person has agreed to pay to the Issuer the profit realized in connection with the short-swing transaction, less transaction costs.

F2 · price: The reported securities consist of shares of common stock sold together with accompanying warrants to purchase common stock. The combined price of each share of common stock offered together with one warrant was $4.00.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 01:58 UTC GENELUX Corp GNLX · Entity 1116 SaleCommon Stock 1,927 $13.93 $26,838.68
Disclosure

SEC source: 0001209191-23-058709 · doc4.xml · nonDerivative · entry 2

Thomas John · CIK 0001939103 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 463,460

F2 · price: The weighted average sale price for the transaction reported was $13.9277, and the range of prices were between $13.80 and $14.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Read SEC document
December 13, 2023 Filed Dec 15, 2023 01:58 UTC GENELUX Corp GNLX · Entity 1116 SaleCommon Stock 7,073 $13.23 $93,548.21
Disclosure

SEC source: 0001209191-23-058709 · doc4.xml · nonDerivative · entry 1

Thomas John · CIK 0001939103 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 465,387

F1 · price: The weighted average sale price for the transaction reported was $13.2261, and the range of prices were between $12.76 and $13.75. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Read SEC document
October 16, 2023 Filed Oct 16, 2023 22:39 UTC GENELUX Corp GNLX · Entity 1116 SaleCommon Stock 881 $21.30 $18,768.56
Disclosure

SEC source: 0001209191-23-052904 · doc4.xml · nonDerivative · entry 2

Thomas John · CIK 0001939103 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 472,460

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2023.

F3 · price: The weighted average sale price for the transaction reported was $21.3037, and the range of prices were between $21.17 and $21.75. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Read SEC document
October 16, 2023 Filed Oct 16, 2023 22:39 UTC GENELUX Corp GNLX · Entity 1116 SaleCommon Stock 2,452 $20.50 $50,269.43
Disclosure

SEC source: 0001209191-23-052904 · doc4.xml · nonDerivative · entry 1

Thomas John · CIK 0001939103 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 473,341

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2023.

F2 · price: The weighted average sale price for the transaction reported was $20.5014, and the range of prices were between $20.10 and $20.97. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Read SEC document
September 18, 2023 Filed Sep 19, 2023 00:12 UTC GENELUX Corp GNLX · Entity 1116 SaleCommon Stock 3,334 $24.99 $83,316.66
Disclosure

SEC source: 0001209191-23-049840 · doc4.xml · nonDerivative · entry 3

Thomas John · CIK 0001939103 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 475,793

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2023.

Read SEC document
September 15, 2023 Filed Sep 19, 2023 00:12 UTC GENELUX Corp GNLX · Entity 1116 SaleCommon Stock 1,088 $22.38 $24,353.57
Disclosure

SEC source: 0001209191-23-049840 · doc4.xml · nonDerivative · entry 2

Thomas John · CIK 0001939103 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 479,127

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2023.

F3 · price: The weighted average sale price for the transaction reported was $22.3838, and the range of prices were between $22.19 and $22.75. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Read SEC document
September 15, 2023 Filed Sep 19, 2023 00:12 UTC GENELUX Corp GNLX · Entity 1116 SaleCommon Stock 2,245 $21.67 $48,642.42
Disclosure

SEC source: 0001209191-23-049840 · doc4.xml · nonDerivative · entry 1

Thomas John · CIK 0001939103 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 480,215

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2023.

F2 · price: The weighted average sale price for the transaction reported was $21.667, and the range of prices were between $21.17 and $22.15. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

Read SEC document
September 11, 2023 Filed Sep 14, 2023 00:15 UTC GENELUX Corp GNLX · Entity 1116 GrantStock Option (Right to Buy) · Derivative 4,397 $0.00 Strike: $22.40 $0.00
Disclosure

SEC source: 0001209191-23-049365 · doc4.xml · derivative · entry 2

Thomas John · CIK 0001939103 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,397

Underlying: Common Stock · 4,397 shares

Expires 2033-09-10

F2 · derivative.exercise_date: The shares subject to the option will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
September 11, 2023 Filed Sep 14, 2023 00:15 UTC GENELUX Corp GNLX · Entity 1116 GrantCommon Stock 3,460 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-049365 · doc4.xml · nonDerivative · entry 1

Thomas John · CIK 0001939103 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 482,460

F1 · kind: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will vest upon the earlier of (a) the one-year anniversary of the date of grant and (b) the date of the Issuer's next annual meeting of stockholders.

Read SEC document
February 17, 2023 Filed May 2, 2023 20:28 UTC GENELUX Corp GNLX · Entity 1116 GrantCommon Stock 9,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-026507 · doc4.xml · nonDerivative · entry 1

Thomas John · CIK 0001939103 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 479,000

F1 · kind: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will be fully vested on July 25, 2023.

Read SEC document
January 30, 2023 Filed Jan 30, 2023 21:28 UTC GENELUX Corp GNLX · Entity 1116 ConversionSeries A Preferred Stock · Derivative 1,410,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-005478 · doc4.xml · derivative · entry 2

Thomas John · CIK 0001939103 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 470,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series A Preferred Stock automatically converted into shares of Common Stock at a conversion ratio of 1 share of Common Stock for each 3 shares of Preferred Stock upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date.

F1 · price: Each share of Series A Preferred Stock automatically converted into shares of Common Stock at a conversion ratio of 1 share of Common Stock for each 3 shares of Preferred Stock upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date.

F1 · derivative.exercise_date: Each share of Series A Preferred Stock automatically converted into shares of Common Stock at a conversion ratio of 1 share of Common Stock for each 3 shares of Preferred Stock upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date.

F1 · derivative.expiration_date: Each share of Series A Preferred Stock automatically converted into shares of Common Stock at a conversion ratio of 1 share of Common Stock for each 3 shares of Preferred Stock upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date.

Read SEC document
January 30, 2023 Filed Jan 30, 2023 21:28 UTC GENELUX Corp GNLX · Entity 1116 ConversionCommon Stock 470,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-005478 · doc4.xml · nonDerivative · entry 1

Thomas John · CIK 0001939103 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 470,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Series A Preferred Stock automatically converted into shares of Common Stock at a conversion ratio of 1 share of Common Stock for each 3 shares of Preferred Stock upon the closing of the Issuer's initial public offering. The Series A Preferred Stock had no expiration date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.